Physician profile
Akram Ibrahim
NPI 1508029802
$36,852.16
in general payments reported to CMS, 2019-2025
41 companies · $5,393 in 2025
The $5,393 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $967 · 2020: $1,138 · 2021: $19K · 2022: $4,244 · 2023: $3,772 · 2024: $2,621 · 2025: $5,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,850 · Travel and Lodging: $3,934 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,850.47 |
| Travel and Lodging | $3,934.27 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,786.38 | 2021-2025 | Micra, Corevalve Evolut R, Linq II |
| Abbott Laboratories | $5,300.30 | 2019-2025 | Aveir, Triclip, Mitraclip |
| Edwards Lifesciences Corporation | $2,818.71 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Abiomed | $1,470.15 | 2021-2025 | Impella |
| Boston Scientific Corporation | $1,279.69 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Shockwave Medical, INC | $1,205.52 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $1,021.97 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $553.37 | 2019-2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $468.59 | 2019-2023 | |
| Cvrx, INC. | $336.81 | 2022-2025 | Barostim Neo System |
| Philips North America LLC | $250.79 | 2023-2025 | Coronary Other, (6536) Phoenix, Ambulatory Monitoring & Diagnostics Undivided |
| Amgen INC. | $201.66 | 2020-2024 | Repatha |
| Cardiva Medical, INC. | $193.94 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Esophageal Cooling Device |
| Medtronic Vascular, INC. | $170.67 | 2019-2020 | |
| Pfizer INC. | $158.34 | 2019-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akram Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.